The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The primary aim of this study is to determine the safest and most effective therapeutic strategy to decrease the incidence of postoperative atrial fibrillation following cardiac surgery in an era with shorter ICU and hospital length of stay. A secondary goal is to evaluate the length of hospital stay associated with each treatment strategy.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
adult patients undergoing open heart surgery
age > or = to 18 years
undergoing either coronary artery bypass graft surgery (CABG), valvular heart surgery or a combined procedure
received a class-I or class-III antiarrhythmic agent in the past six months
had second or third degree heart block
had a resting heart rate of less than 50 beats per minute
had a systolic blood pressure less than 100 mmHg
had severe asthma or severe chronic obstructive pulmonary disease
had uncontrolled heart failure
had a serum aspartate aminotransferase or alanine aminotransferase concentration greater than four times the upper limit of normal